Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Practical Application of Periostin as a Biomarker for Pathological Conditions.

Kii I.

Adv Exp Med Biol. 2019;1132:195-204. doi: 10.1007/978-981-13-6657-4_18. Review.

PMID:
31037636
2.

Periostin Functions as a Scaffold for Assembly of Extracellular Proteins.

Kii I.

Adv Exp Med Biol. 2019;1132:23-32. doi: 10.1007/978-981-13-6657-4_3. Review.

PMID:
31037621
3.

Screening of novel drugs for inhibiting hepatitis E virus replication.

Nishiyama T, Kobayashi T, Jirintai S, Kii I, Nagashima S, Prathiwi Primadharsini P, Nishizawa T, Okamoto H.

J Virol Methods. 2019 Aug;270:1-11. doi: 10.1016/j.jviromet.2019.04.017. Epub 2019 Apr 17.

PMID:
31004661
4.

A facile preparation of functional cycloalkynes via an azide-to-cycloalkyne switching approach.

Yoshida S, Kuribara T, Ito H, Meguro T, Nishiyama Y, Karaki F, Hatakeyama Y, Koike Y, Kii I, Hosoya T.

Chem Commun (Camb). 2019 Mar 19;55(24):3556-3559. doi: 10.1039/c9cc01113g.

PMID:
30843553
5.

Alzheimer Aβ Assemblies Accumulate in Excitatory Neurons upon Proteasome Inhibition and Kill Nearby NAKα3 Neurons by Secretion.

Komura H, Kakio S, Sasahara T, Arai Y, Takino N, Sato M, Satomura K, Ohnishi T, Nabeshima YI, Muramatsu SI, Kii I, Hoshi M.

iScience. 2019 Mar 29;13:452-477. doi: 10.1016/j.isci.2019.01.018. Epub 2019 Feb 28.

6.
7.

Staudinger reaction using 2,6-dichlorophenyl azide derivatives for robust aza-ylide formation applicable to bioconjugation in living cells.

Meguro T, Terashima N, Ito H, Koike Y, Kii I, Yoshida S, Hosoya T.

Chem Commun (Camb). 2018 Jul 12;54(57):7904-7907. doi: 10.1039/c8cc00179k.

PMID:
29785430
8.
9.

Quantification of receptor activation by oxytocin and vasopressin in endocytosis-coupled bioluminescence reduction assay using nanoKAZ.

Kii I, Hirahara-Owada S, Yamaguchi M, Niwa T, Koike Y, Sonamoto R, Ito H, Takahashi K, Yokoyama C, Hayashi T, Hosoya T, Watanabe Y.

Anal Biochem. 2018 May 15;549:174-183. doi: 10.1016/j.ab.2018.04.001. Epub 2018 Apr 5.

PMID:
29627593
10.

Convergent synthesis of trifunctional molecules by three sequential azido-type-selective cycloadditions.

Yoshida S, Kanno K, Kii I, Misawa Y, Hagiwara M, Hosoya T.

Chem Commun (Camb). 2018 Apr 10;54(30):3705-3708. doi: 10.1039/c8cc01195h.

PMID:
29527608
11.

Periostin function in communication with extracellular matrices.

Kudo A, Kii I.

J Cell Commun Signal. 2018 Mar;12(1):301-308. doi: 10.1007/s12079-017-0422-6. Epub 2017 Oct 30. Review.

12.

Periostin and its interacting proteins in the construction of extracellular architectures.

Kii I, Ito H.

Cell Mol Life Sci. 2017 Dec;74(23):4269-4277. doi: 10.1007/s00018-017-2644-4. Epub 2017 Sep 8. Review.

PMID:
28887577
13.

Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice.

Nakano-Kobayashi A, Awaya T, Kii I, Sumida Y, Okuno Y, Yoshida S, Sumida T, Inoue H, Hosoya T, Hagiwara M.

Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10268-10273. doi: 10.1073/pnas.1704143114. Epub 2017 Sep 5.

15.

DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain.

Abu Jhaisha S, Widowati EW, Kii I, Sonamoto R, Knapp S, Papadopoulos C, Becker W.

Sci Rep. 2017 Jul 25;7(1):6420. doi: 10.1038/s41598-017-06874-w.

16.

Three-Dimensional Localization of an Individual Fluorescent Molecule with Angstrom Precision.

Furubayashi T, Motohashi K, Wakao K, Matsuda T, Kii I, Hosoya T, Hayashi N, Sadaie M, Ishikawa F, Matsushita M, Fujiyoshi S.

J Am Chem Soc. 2017 Jul 5;139(26):8990-8994. doi: 10.1021/jacs.7b03899. Epub 2017 Jun 23.

PMID:
28644014
17.

Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy.

Sako Y, Ninomiya K, Okuno Y, Toyomoto M, Nishida A, Koike Y, Ohe K, Kii I, Yoshida S, Hashimoto N, Hosoya T, Matsuo M, Hagiwara M.

Sci Rep. 2017 May 30;7:46126. doi: 10.1038/srep46126.

18.

Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity.

Kawaguchi K, Suzuki E, Nishie M, Kii I, Kataoka TR, Hirata M, Inoue M, Pu F, Iwaisako K, Tsuda M, Yamaguchi A, Haga H, Hagiwara M, Toi M.

Cancer Immunol Immunother. 2017 Sep;66(9):1131-1142. doi: 10.1007/s00262-017-2002-2. Epub 2017 Apr 21.

PMID:
28432397
19.

Periostin is required for matricellular localization of CCN3 in periodontal ligament of mice.

Takayama I, Tanabe H, Nishiyama T, Ito H, Amizuka N, Li M, Katsube KI, Kii I, Kudo A.

J Cell Commun Signal. 2017 Mar;11(1):5-13. doi: 10.1007/s12079-016-0371-5. Epub 2016 Dec 24.

20.

Periostin Deficiency Causes Severe and Lethal Lung Injury in Mice With Bleomycin Administration.

Kondoh H, Nishiyama T, Kikuchi Y, Fukayama M, Saito M, Kii I, Kudo A.

J Histochem Cytochem. 2016 Jul;64(7):441-53. doi: 10.1369/0022155416652611. Epub 2016 Jun 7.

21.

Selective inhibition of the kinase DYRK1A by targeting its folding process.

Kii I, Sumida Y, Goto T, Sonamoto R, Okuno Y, Yoshida S, Kato-Sumida T, Koike Y, Abe M, Nonaka Y, Ikura T, Ito N, Shibuya H, Hosoya T, Hagiwara M.

Nat Commun. 2016 Apr 22;7:11391. doi: 10.1038/ncomms11391.

22.

Periostin promotes secretion of fibronectin from the endoplasmic reticulum.

Kii I, Nishiyama T, Kudo A.

Biochem Biophys Res Commun. 2016 Feb 19;470(4):888-93. doi: 10.1016/j.bbrc.2016.01.139. Epub 2016 Jan 26.

PMID:
26820539
23.

Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ.

Sonamoto R, Kii I, Koike Y, Sumida Y, Kato-Sumida T, Okuno Y, Hosoya T, Hagiwara M.

Sci Rep. 2015 Aug 3;5:12728. doi: 10.1038/srep12728.

24.

Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly.

Ohnishi T, Yanazawa M, Sasahara T, Kitamura Y, Hiroaki H, Fukazawa Y, Kii I, Nishiyama T, Kakita A, Takeda H, Takeuchi A, Arai Y, Ito A, Komura H, Hirao H, Satomura K, Inoue M, Muramatsu S, Matsui K, Tada M, Sato M, Saijo E, Shigemitsu Y, Sakai S, Umetsu Y, Goda N, Takino N, Takahashi H, Hagiwara M, Sawasaki T, Iwasaki G, Nakamura Y, Nabeshima Y, Teplow DB, Hoshi M.

Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4465-74. doi: 10.1073/pnas.1421182112. Epub 2015 Jul 29.

25.

Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis.

Masaki S, Kii I, Sumida Y, Kato-Sumida T, Ogawa Y, Ito N, Nakamura M, Sonamoto R, Kataoka N, Hosoya T, Hagiwara M.

Bioorg Med Chem. 2015 Aug 1;23(15):4434-41. doi: 10.1016/j.bmc.2015.06.018. Epub 2015 Jun 14.

PMID:
26145823
26.

Identification of a Dual Inhibitor of SRPK1 and CK2 That Attenuates Pathological Angiogenesis of Macular Degeneration in Mice.

Morooka S, Hoshina M, Kii I, Okabe T, Kojima H, Inoue N, Okuno Y, Denawa M, Yoshida S, Fukuhara J, Ninomiya K, Ikura T, Furuya T, Nagano T, Noda K, Ishida S, Hosoya T, Ito N, Yoshimura N, Hagiwara M.

Mol Pharmacol. 2015 Aug;88(2):316-25. doi: 10.1124/mol.114.097345. Epub 2015 May 20.

PMID:
25993998
27.

CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.

Yamamoto M, Onogi H, Kii I, Yoshida S, Iida K, Sakai H, Abe M, Tsubota T, Ito N, Hosoya T, Hagiwara M.

J Clin Invest. 2014 Aug;124(8):3479-88. doi: 10.1172/JCI73805. Epub 2014 Jul 8.

28.

Alleviation of behavioral hypersensitivity in mouse models of inflammatory pain with two structurally different casein kinase 1 (CK1) inhibitors.

Kurihara T, Sakurai E, Toyomoto M, Kii I, Kawamoto D, Asada T, Tanabe T, Yoshimura M, Hagiwara M, Miyata A.

Mol Pain. 2014 Mar 10;10:17. doi: 10.1186/1744-8069-10-17.

29.

The niche component periostin is produced by cancer-associated fibroblasts, supporting growth of gastric cancer through ERK activation.

Kikuchi Y, Kunita A, Iwata C, Komura D, Nishiyama T, Shimazu K, Takeshita K, Shibahara J, Kii I, Morishita Y, Yashiro M, Hirakawa K, Miyazono K, Kudo A, Fukayama M, Kashima TG.

Am J Pathol. 2014 Mar;184(3):859-70. doi: 10.1016/j.ajpath.2013.11.012. Epub 2014 Jan 10.

PMID:
24418260
30.

[Double click reaction: a novel method for chemical modification of biomolecules].

Kii I, Yoshida S, Hosoya T.

Seikagaku. 2012 Apr;84(4):306-11. Review. Japanese. No abstract available.

PMID:
22712241
31.

Remodeling of actin cytoskeleton in mouse periosteal cells under mechanical loading induces periosteal cell proliferation during bone formation.

Sakai D, Kii I, Nakagawa K, Matsumoto HN, Takahashi M, Yoshida S, Hosoya T, Takakuda K, Kudo A.

PLoS One. 2011;6(9):e24847. doi: 10.1371/journal.pone.0024847. Epub 2011 Sep 14.

32.

Delayed re-epithelialization in periostin-deficient mice during cutaneous wound healing.

Nishiyama T, Kii I, Kashima TG, Kikuchi Y, Ohazama A, Shimazaki M, Fukayama M, Kudo A.

PLoS One. 2011 Apr 7;6(4):e18410. doi: 10.1371/journal.pone.0018410.

33.

Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma.

Fujiwara M, Kashima TG, Kunita A, Kii I, Komura D, Grigoriadis AE, Kudo A, Aburatani H, Fukayama M.

Tumour Biol. 2011 Jun;32(3):611-22. doi: 10.1007/s13277-011-0160-y. Epub 2011 Mar 1.

PMID:
21360024
34.

Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A.

Ogawa Y, Nonaka Y, Goto T, Ohnishi E, Hiramatsu T, Kii I, Yoshida M, Ikura T, Onogi H, Shibuya H, Hosoya T, Ito N, Hagiwara M.

Nat Commun. 2010 Oct 5;1:86. doi: 10.1038/ncomms1090.

PMID:
20981014
35.

Periostin associates with Notch1 precursor to maintain Notch1 expression under a stress condition in mouse cells.

Tanabe H, Takayama I, Nishiyama T, Shimazaki M, Kii I, Li M, Amizuka N, Katsube K, Kudo A.

PLoS One. 2010 Aug 18;5(8):e12234. doi: 10.1371/journal.pone.0012234.

36.

Strain-promoted double-click reaction for chemical modification of azido-biomolecules.

Kii I, Shiraishi A, Hiramatsu T, Matsushita T, Uekusa H, Yoshida S, Yamamoto M, Kudo A, Hagiwara M, Hosoya T.

Org Biomol Chem. 2010 Sep 21;8(18):4051-5. doi: 10.1039/c0ob00003e. Epub 2010 Jul 26.

PMID:
20657923
37.

Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase.

Maruhashi T, Kii I, Saito M, Kudo A.

J Biol Chem. 2010 Apr 23;285(17):13294-303. doi: 10.1074/jbc.M109.088864. Epub 2010 Feb 24.

38.

Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture.

Kii I, Nishiyama T, Li M, Matsumoto K, Saito M, Amizuka N, Kudo A.

J Biol Chem. 2010 Jan 15;285(3):2028-39. doi: 10.1074/jbc.M109.051961. Epub 2009 Nov 3.

39.

Expression, purification and characterization of soluble recombinant periostin protein produced by Escherichia coli.

Takayama I, Kii I, Kudo A.

J Biochem. 2009 Nov;146(5):713-23. doi: 10.1093/jb/mvp117. Epub 2009 Jul 24.

PMID:
19633058
40.

Periostin, a novel marker of intramembranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions.

Kashima TG, Nishiyama T, Shimazu K, Shimazaki M, Kii I, Grigoriadis AE, Fukayama M, Kudo A.

Hum Pathol. 2009 Feb;40(2):226-37. doi: 10.1016/j.humpath.2008.07.008. Epub 2008 Sep 16.

PMID:
18799196
41.

Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon.

Kikuchi Y, Kashima TG, Nishiyama T, Shimazu K, Morishita Y, Shimazaki M, Kii I, Horie H, Nagai H, Kudo A, Fukayama M.

J Histochem Cytochem. 2008 Aug;56(8):753-64. doi: 10.1369/jhc.2008.951061. Epub 2008 Apr 28.

42.

Periostin is essential for cardiac healing after acute myocardial infarction.

Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, Saito M, Fukuda K, Nishiyama T, Kitajima S, Saga Y, Fukayama M, Sata M, Kudo A.

J Exp Med. 2008 Feb 18;205(2):295-303. doi: 10.1084/jem.20071297. Epub 2008 Jan 21.

43.

[Periostin function in the periodontal ligament and the periosteum].

Kii I, Kudo A.

Clin Calcium. 2007 Feb;17(2):202-8. Review. Japanese.

PMID:
17272877
44.

GFP transgenic mice reveal active canonical Wnt signal in neonatal brain and in adult liver and spleen.

Moriyama A, Kii I, Sunabori T, Kurihara S, Takayama I, Shimazaki M, Tanabe H, Oginuma M, Fukayama M, Matsuzaki Y, Saga Y, Kudo A.

Genesis. 2007 Feb;45(2):90-100.

PMID:
17245775
45.
46.

Periostin is an extracellular matrix protein required for eruption of incisors in mice.

Kii I, Amizuka N, Minqi L, Kitajima S, Saga Y, Kudo A.

Biochem Biophys Res Commun. 2006 Apr 14;342(3):766-72. Epub 2006 Feb 14.

PMID:
16497272
47.

[Function of the fasciclin I family].

Kii I, Kudo A.

Seikagaku. 2006 Jan;78(1):16-26. Review. Japanese. No abstract available.

PMID:
16491908
48.
49.

Immunohistochemical localization of periostin in tooth and its surrounding tissues in mouse mandibles during development.

Suzuki H, Amizuka N, Kii I, Kawano Y, Nozawa-Inoue K, Suzuki A, Yoshie H, Kudo A, Maeda T.

Anat Rec A Discov Mol Cell Evol Biol. 2004 Dec;281(2):1264-75.

50.

Inactivation of Rho/ROCK signaling is crucial for the nuclear accumulation of FKHR and myoblast fusion.

Nishiyama T, Kii I, Kudo A.

J Biol Chem. 2004 Nov 5;279(45):47311-9. Epub 2004 Aug 22.

Supplemental Content

Support Center